20974 29Metals AR23 WEB V1 - Flipbook - Page 137
4, 32
3 ,0 3
0 ,000
2, 9
ac ui Mc ill AO
Martin Alciaturi
Tamara rown
Creagh O’Connor
.
2.
3.
4.
.
.
0.
9.
,23
3
ϭϰϱ͕ϲϳϱ
30, 4
3 ,3
ϲϭ͕ϱϵϬ
—
—
2,0
4
—
,44
ϰ͕ϳϯϯ
ϭϱϬ͕ϳϭϮ
,4
,994
( ,
—
—
—
—
—
—
2 ,34
2 ,34
2 ,34
2 ,34
—
330
,92
20,
,203
)
—
ϰϴϳ͕ϬϮϮ
2 2, 4
2 3,
249, 92
(2 , 03)
—
—
—
—
—
—
0
0
0
,
ϴϯϭ͕ϴϲϯ
2,4 9
2,4 9
2,4 9
4, 9
—
, 49
2 ,22
2 ,22
2 ,22
9
ϵϬϯ͕ϰϮϲ
—
—
—
903,42
—
—
—
—
—
—
ϲ͕ϭϬϱ͕ϰϰϳ
9,223
,0 2
9 3,
, 9 , 3
2, 9
2,0 9
40 ,22
42 ,22
42 ,22
2 0,000
$
Total
(
)
EͬĂ
34
34
3
Na
Na
Na
Na
Na
Na
%
Performance-related
Sustainability
& ESG Report
.
.
4.
.
.
ϭϮϱ͕ϲϳϴ
42, 40
42, 4
40,4 3
9, 29
—
—
—
—
—
—
$
Termination
payments
Comprises value of accrued annual leave entitlements.
Comprises accrued long service leave entitlements, including accrued entitlements transferred upon commencement of employment with 29Metals.
Share options comprises performance rights awarded to e ecutive MPs (nil e ercise price). or the Reporting period, performance rights were awarded under the 2023 TI (refer to section 4.4) and the 2023 STI (e uity component refer to section 4.3). The value of performance rights awarded to
e ecutive MPs in the Reporting Period is calculated by applying the ĨĂŝƌǀĂůƵĞper performance right calculated for each award. Information regarding the ĨĂŝƌǀĂůƵĞ applied for awards of performance rights during the Reporting period is set out in section 4. .
Shares issued to MPs during the Reporting Period and applying ĨĂŝƌǀĂůƵĞ determined for each relevant issue.
Owen egarty is a nominee director for EMR Capital Investors (as that term is defined in the 29Metals Prospectus), Mr egarty’s Director’s fees are paid to EMR Capital.
ees paid to Ms Robertson, Ms Mc ill, Mr Alciaturi and Ms rown are cited net of fees delivered in the form of fully paid 29Metals shares issued to each of them in under the NED Share Plan. The fees applied (by way of salary sacrifice) for the issue of shares under the NED Share Plan was 40,000
during the Reporting Period (per Director). These benefits are included in ^ŚĂƌĞͲďĂƐĞĚWĂLJŵĞŶƚƐ(Refer to note , below). Refer to section . for further information regarding the NED Share Plan.
Refer to section .4 for information regarding the ĨĂŝƌǀĂůƵĞ applied for shares issued to eligible NEDs under the NED Share Plan. Share based payments reflect the total value of shares issued (or estimate value of shares e pected to be issued) for accounting purposes and is based off the fair value
calculation (refer to Note 3 (b)(v) to the Consolidated inancial Statements for the year ended 3 December 2023). or accounting purposes, fair value calculations are determined with reference to the Company’s share price as at the time of shareholder approval (being 2. per share, for eligible
NEDs in office on 24 May 2022) or date of appointment as a Director (being .3 per share, for Ms rown), whichever is later. The actual contribution and amounts paid by Non e ecutive Directors participating in the NED Salary Sacrifice Share Plan is up to 40,000 per annum. Refer to section . for
further information.
nder the terms of the CEO Transition, unvested performance rights awarded to Mr Albert under the 202 , 2022 and 2023 TI will lapse and be forfeited upon Mr Albert’s retirement on 30 April 2024. Share based payments cited in the table include the reversal of the previously recognised e pense
for the performance rights awarded under the 202 and 2022 TI. Refer to section 3. for further information regarding the CEO Transition.
or statutory remuneration reporting purposes, 29Metals is re uired to include amounts payable to Mr Albert at termination under the CEO Transition terms, similarly, an accrual for these future benefits, payable on termination, is included in the Consolidated inancial Statements (refer to Note
34(b)(vi) to the Consolidated inancial Statements). Relevant amounts are not due and payable to Mr Albert before 30 April 2024, and no termination benefits were remitted during the Reporting Period and up to the date of this Report. Statutory remuneration reporting for the 2024 reporting period
will not include this amount on the basis that it has been reported against the 2023 Reporting Period. Refer to section 3. for further information regarding the terms of the CEO Transition.
Shares issued to e ecutive MPs during the Reporting Period on vesting of Performance Rights awarded to e ecutive MPs under the Staff Offer Incentive. Refer to section 4. for further information regarding the Staff Offer Incentive. The value of shares issued to e ecutive MPs in the Reporting
Period is calculated by applying the ĨĂŝƌǀĂůƵĞof 2.00 per share for each issue.
Comprises regular airfares, travel e penses and accommodation for Mr Cooney to commute between Sydney and Melbourne during the Reporting Period. T applicable is included in ‘Non monetary benefits’.
Salary for Mr erbert for the Reporting Period includes a temporary increase in T R for a period during which Mr erbert was acting CEO while Mr Albert was on annual leave. The aggregate incremental T R for the relevant period was 3, 9 (inclusive of superannuation contributions).
Salary for Mr Tuc includes a payment of 9, 9 for annual leave cashed out during the Reporting Period.
Comprises legal fees paid by the Company on Mr Albert’s behalf, in connection with the CEO Transition arrangements. Refer to section 3. for further information regarding the CEO Transition terms.
Creagh O’Connor is a nominee director for EMR Capital Investors (as that term is defined in the 29Metals Prospectus). EMR Capital have directed that fees are paid directly to Mr O’Connor. Director’s fees are paid to an entity related to Mr O’Connor.
Includes T payable on regular airfares, travel e penses and accommodation for Mr Cooney to commute between Sydney and Melbourne during the Reporting Period.
ϯ͕ϯϵϰ͕ϲϱϴ
3
2
2 ,222
—
—
—
—
—
—
Share-based payments
Share
options3
Shares4
$
$
Our
assets
.
2.
3.
dŽƚĂů
9,0 2
Clifford Tuc
,4 2
2 , 0
—
Na
Na
Na
Na
Na
Na
Superannuation
$
Employee
entitlements2
$
Long-term
benefits
About
29Metals
Peter erbert
Ed Cooney
KƚŚĞƌĞdžĞĐƵƚŝǀĞ
